
Robert John Sandy
Examiner (ID: 15001)
| Most Active Art Unit | 3677 |
| Art Unit(s) | 3507, 3677, 3624, 3626 |
| Total Applications | 2310 |
| Issued Applications | 1883 |
| Pending Applications | 76 |
| Abandoned Applications | 355 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14759501
[patent_doc_number] => 10391129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Microbiota restoration therapy (MRT), compositions and methods of manufacture
[patent_app_type] => utility
[patent_app_number] => 15/591758
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19200
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591758 | Microbiota restoration therapy (MRT), compositions and methods of manufacture | May 9, 2017 | Issued |
Array
(
[id] => 13519731
[patent_doc_number] => 20180311408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => AMNION BASED CONDUIT TISSUE
[patent_app_type] => utility
[patent_app_number] => 15/583906
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/583906 | AMNION BASED CONDUIT TISSUE | Apr 30, 2017 | Abandoned |
Array
(
[id] => 14007737
[patent_doc_number] => 10222320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Identifying and enumerating early granulated cells (EGCs)
[patent_app_type] => utility
[patent_app_number] => 15/489488
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 7811
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15489488
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/489488 | Identifying and enumerating early granulated cells (EGCs) | Apr 16, 2017 | Issued |
Array
(
[id] => 13493601
[patent_doc_number] => 20180298343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => COMPOSITIONS AND METHODS FOR A THREE DIMENSIONAL EX-VIVO GLOMERULAR CELL CO-CULTURE BIOLOGICAL ENGINEERING MODEL
[patent_app_type] => utility
[patent_app_number] => 15/486189
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/486189 | COMPOSITIONS AND METHODS FOR A THREE DIMENSIONAL EX-VIVO GLOMERULAR CELL CO-CULTURE BIOLOGICAL ENGINEERING MODEL | Apr 11, 2017 | Abandoned |
Array
(
[id] => 15306627
[patent_doc_number] => 10517996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Bioengineered allogeneic blood vessel
[patent_app_type] => utility
[patent_app_number] => 15/481862
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 107
[patent_no_of_words] => 12747
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481862
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481862 | Bioengineered allogeneic blood vessel | Apr 6, 2017 | Issued |
Array
(
[id] => 11715127
[patent_doc_number] => 20170183626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'DEFINED MEDIA FOR EXPANSION AND MAINTENANCE OF PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/457952
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 9223
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/457952 | DEFINED MEDIA FOR EXPANSION AND MAINTENANCE OF PLURIPOTENT STEM CELLS | Mar 12, 2017 | Abandoned |
Array
(
[id] => 14169495
[patent_doc_number] => 10258734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Devices, systems and methods for cell modification
[patent_app_type] => utility
[patent_app_number] => 15/453817
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6331
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453817
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453817 | Devices, systems and methods for cell modification | Mar 7, 2017 | Issued |
Array
(
[id] => 15636953
[patent_doc_number] => 10591462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Electrochemical method and device for detecting the effect of anticancer drugs
[patent_app_type] => utility
[patent_app_number] => 15/447415
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 7761
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15447415
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/447415 | Electrochemical method and device for detecting the effect of anticancer drugs | Mar 1, 2017 | Issued |
Array
(
[id] => 13372561
[patent_doc_number] => 20180237821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => APPARATUS AND METHOD TO READ BIOLOGICAL INDICATOR
[patent_app_type] => utility
[patent_app_number] => 15/440360
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440360
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440360 | APPARATUS AND METHOD TO READ BIOLOGICAL INDICATOR | Feb 22, 2017 | Abandoned |
Array
(
[id] => 12880357
[patent_doc_number] => 20180185294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => MYCO Capsule
[patent_app_type] => utility
[patent_app_number] => 15/438898
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15438898
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/438898 | MYCO Capsule | Feb 21, 2017 | Abandoned |
Array
(
[id] => 11850291
[patent_doc_number] => 20170224783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/429132
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12468
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429132
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429132 | METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS | Feb 8, 2017 | Abandoned |
Array
(
[id] => 14291787
[patent_doc_number] => 10286001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
[patent_app_type] => utility
[patent_app_number] => 15/419241
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6889
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15419241
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/419241 | Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics | Jan 29, 2017 | Issued |
Array
(
[id] => 11602410
[patent_doc_number] => 20170119710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'TREATMENT OF CONDITIONS RELATED TO SHOCK'
[patent_app_type] => utility
[patent_app_number] => 15/404002
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6576
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15404002
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/404002 | TREATMENT OF CONDITIONS RELATED TO SHOCK | Jan 10, 2017 | Abandoned |
Array
(
[id] => 11647874
[patent_doc_number] => 20170143776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'FORMULATION AND TREATMENT FOR ACNE'
[patent_app_type] => utility
[patent_app_number] => 15/369660
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4682
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15369660
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/369660 | Formulation and treatment for acne | Dec 4, 2016 | Issued |
Array
(
[id] => 11601644
[patent_doc_number] => 20170118943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'Endophytes and related methods'
[patent_app_type] => utility
[patent_app_number] => 15/359993
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 114
[patent_figures_cnt] => 114
[patent_no_of_words] => 27614
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359993
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359993 | Endophytes and related methods | Nov 22, 2016 | Abandoned |
Array
(
[id] => 11500583
[patent_doc_number] => 20170074769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'SPECIMEN EVALUATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/359930
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 6388
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359930
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359930 | SPECIMEN EVALUATION METHOD | Nov 22, 2016 | Abandoned |
Array
(
[id] => 11471478
[patent_doc_number] => 20170058261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'Augmentation of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase'
[patent_app_type] => utility
[patent_app_number] => 15/347500
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13182
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347500
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347500 | Augmentation of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase | Nov 8, 2016 | Abandoned |
Array
(
[id] => 11588553
[patent_doc_number] => 20170112964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'METHOD AND COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASE WITHOUT COLECTOMY'
[patent_app_type] => utility
[patent_app_number] => 15/343138
[patent_app_country] => US
[patent_app_date] => 2016-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8690
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343138
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343138 | METHOD AND COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASE WITHOUT COLECTOMY | Nov 2, 2016 | Abandoned |
Array
(
[id] => 11455920
[patent_doc_number] => 20170049826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE'
[patent_app_type] => utility
[patent_app_number] => 15/341267
[patent_app_country] => US
[patent_app_date] => 2016-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20632
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15341267
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/341267 | Microbiota restoration therapy (MRT), compositions and methods of manufacture | Nov 1, 2016 | Issued |
Array
(
[id] => 11455921
[patent_doc_number] => 20170049827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE'
[patent_app_type] => utility
[patent_app_number] => 15/341303
[patent_app_country] => US
[patent_app_date] => 2016-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22538
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15341303
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/341303 | Microbiota restoration therapy (MRT), compositions and methods of manufacture | Nov 1, 2016 | Issued |